Insider Trading & Ownership - SCHIFF ANDREW N

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHIFF ANDREW N
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-10
Sale
2022-11-14
4:51 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
53,926$17.05$919,589434,455
(Indirect
Direct)
View
2022-10-24
Sale
2022-10-26
7:09 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
41,174$17.01$700,355488,381
(Indirect
Direct)
View
2022-10-17
Sale
2022-10-19
4:49 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
52,037$16.57$862,109529,555
(Indirect
Direct)
View
2022-10-07
Sale
2022-10-11
4:35 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
7,324$16.16$118,349581,592
(Indirect
Direct)
View
2022-10-04
Sale
2022-10-06
5:58 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
45,539$16.45$749,002588,916
(Indirect
Direct)
View
2022-06-17
Sale
2022-06-21
4:57 pm
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
19,565$15.14$296,269634,455
(Indirect
Direct)
View
2021-06-29
Purchase
2021-07-01
6:29 pm
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
187,500$16$3,000,0002,834,910
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-12
Option Award
2024-06-13
4:30 pm
N/A
2034-06-12
Monte Rosa Therapeutics Inc.GLUESCHIFF ANDREW N
Director
22,100$022,100
(Direct)
View
2024-06-06
Option Award
2024-06-10
4:15 pm
N/A
2034-06-05
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
20,543$020,543
(Direct)
View
2024-06-01
Exercise
2024-06-04
4:30 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
4,660$0443,622
(Direct)
View
2023-06-16
Option Award
2023-06-21
4:09 pm
N/A
2033-06-15
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
31,238$031,238
(Indirect)
View
2023-06-14
Option Award
2023-06-15
4:28 pm
N/A
2033-06-13
Monte Rosa Therapeutics Inc.GLUESCHIFF ANDREW N
Director
20,500$020,500
(Direct)
View
2023-06-02
Exercise
2023-06-05
4:53 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
4,507$0459,372
(Direct)
View
2023-06-01
Option Award
2023-06-05
4:53 pm
N/A
2033-05-31
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
20,410$0459,372
(Direct)
View
2022-06-17
Option Award
2022-06-22
6:43 pm
N/A
2032-06-16
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
15,619$015,619
(Indirect)
View
2022-06-15
Option Award
2022-06-16
4:31 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUESCHIFF ANDREW N
Director
15,000$015,000
(Direct)
View
2022-06-03
Exercise
2022-06-06
5:36 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
3,356$0674,277
(Direct)
View
2022-06-02
Option Award
2022-06-06
5:36 pm
N/A
2032-06-01
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
20,257$0674,277
(Direct)
View
2021-06-29
Conversion
2021-07-01
6:29 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
12,288,426$02,834,910
(Direct)
View
2021-06-24
Option Award
2021-06-28
6:18 pm
N/A
2031-06-23
Elevation Oncology Inc.ELEVAisling Capital IV LP
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
ELMS STEVE
SCHIFF ANDREW N
10% Owner
31,238$031,238
(Indirect)
View
2021-06-23
Option Award
2021-06-25
5:01 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc.GLUESCHIFF ANDREW N
Director
47,132$047,132
(Direct)
View

Ownership
2021-06-24
6:32 pm
N/A
N/A
Elevation Oncology Inc.ELEVAisling Capital IV LP
ELMS STEVE
Aisling Capital Partners IV LLC
Aisling Capital Partners IV LP
SCHIFF ANDREW N
10% Owner
0$02,647,410
(Direct)
View
2021-06-03
Option Award
2021-06-04
8:12 pm
N/A
2031-06-02
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
15,606$015,606
(Direct)
View
2020-06-06
Exercise
2020-06-08
5:27 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
7,333$0667,164
(Direct)
View
2020-06-04
Option Award
2020-06-08
5:27 pm
N/A
2030-06-03
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
16,500$0667,164
(Direct)
View
2020-03-02
Exercise
2020-03-04
4:28 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
8,876$0652,207
(Direct)
View
2020-03-02
Option Award
2020-03-04
4:28 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSSCHIFF ANDREW N
Director
8,876$0652,207
(Direct)
View
2019-12-02
Option Award
2019-12-06
10:23 am
N/A
N/A
Zosano Pharma CorpZSANAisling Capital IV LP
Aisling Capital Partners IV LP
Aisling Capital Partners IV LLC
ELMS STEVE
SCHIFF ANDREW N
10% Owner
689,655$1.452,718,226
(Direct)
View